Zhejiang Hengtong Hits Day High with Strong 3.76% Intraday Surge

Zhejiang Hengtong Holding Co., a prominent player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, gaining 3.76% on May 22, 2026. The stock reached an intraday high of CNY 6.14, reflecting its strong performance relative to the broader market. Over the past week, Zhejiang Hengtong has outperformed the China Shanghai Composite, with a weekly gain of 7.62% compared to the index's decline of 0.54%. The company's one-month performance stands at an impressive 13.88%, while its year-to-date performance is also notable at 13.88%, significantly surpassing the index's 3.63%. In the past year, Zhejiang Hengtong has achieved a remarkable return of 107.17%, far exceeding the China Shanghai Composite's 21.68%. However, the company faces challenges with a high debt-equity ratio of 8.99% and rising raw material costs, which have increased by 32.65% year-over-year. Despite these factors, the stock's current valuation metrics, including a price-to-book ratio of 4.74, indicate a complex financial landscape for investors to consider.